TipRanks
Go Ultimate55% OFF

Wai Yuen Tong Medicine Holdings Limited (0897) Stock Price & Analysis

0897 Stock Chart & Stats

HK$0.36HK$0.02(5.88%)
At close: 4:00 PM GMT+8
HK$0.3HK$0.354 Aug17 Aug31 Aug14 Sep28 Sep12 Oct27 Oct
Day’s Range
HKD 0.35 - HKD 0.39
52-Week Range
HKD 0.27 - HKD 0.49
Previous Close
HKD 0.34
Volume
490.00K
Average Volume (3M)
512.27K
Market Cap
HKD 401.18M
Enterprise Value
HKD 560.58M
Total Cash (Recent Filing)
HKD 147.44M
Total Debt (Recent Filing)
HKD 279.29M
Price to Earnings (P/E)
100.0
Beta
0.70
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Deleveraging

The sharp reduction in debt materially lowers financial risk and interest-related pressure, giving Wai Yuen Tong greater flexibility to sustain operations and fund priorities. A much healthier capital structure also improves resilience if revenue remains under pressure over the next several quarters.

Positive Cash Generation

Positive operating and free cash flow show that the business is generating cash despite very thin reported earnings. This provides an internal source for working capital and investment, reduces reliance on external financing, and supports stability after the company’s substantial deleveraging.

Improved Gross Margin

The higher gross margin indicates better product mix or gross-level economics than in 2023, while the return to positive net income marks progress from earlier loss years. If maintained, this improvement can help the retail and distribution model absorb cost pressure and rebuild earnings power.

Bears Say

Revenue Contraction

Persistent revenue contraction points to a weakening scale base for the retail and distribution operations. Lower sales can reduce operating leverage, limit the company’s ability to spread fixed costs, and make it harder for margin improvements to translate into durable profit growth.

Weak Operating Profitability

Very thin net margins leave little buffer against ongoing expenses or weaker trading, while negative operating profit shows that core operations are not yet consistently profitable. This weak earnings quality limits reinvestment capacity and makes future results sensitive to modest cost or sales changes.

Declining Cash Momentum

Although free cash flow remains positive, the sharp year-over-year decline and historical volatility reduce confidence that cash generation is consistently improving. Less dependable cash conversion could constrain investment and capital allocation if revenue weakness or operating pressures persist.

Wai Yuen Tong Medicine Holdings Limited News

0897 FAQ

What was Wai Yuen Tong Medicine Holdings Limited’s price range in the past 12 months?
Wai Yuen Tong Medicine Holdings Limited lowest stock price was HK$0.27 and its highest was HK$0.49 in the past 12 months.
What is Wai Yuen Tong Medicine Holdings Limited’s market cap?
Wai Yuen Tong Medicine Holdings Limited’s market cap is HK$401.18M.
When is Wai Yuen Tong Medicine Holdings Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wai Yuen Tong Medicine Holdings Limited’s earnings last quarter?
Wai Yuen Tong Medicine Holdings Limited released its earnings results on Jun 25, 2026. The company reported HK$0.001 earnings per share for the quarter.
Is Wai Yuen Tong Medicine Holdings Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Wai Yuen Tong Medicine Holdings Limited pay dividends?
Wai Yuen Tong Medicine Holdings Limited pays a Notavailable dividend of HK$0.177 which represents an annual dividend yield of ―. See more information on Wai Yuen Tong Medicine Holdings Limited dividends here
What is Wai Yuen Tong Medicine Holdings Limited’s EPS estimate?
Wai Yuen Tong Medicine Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wai Yuen Tong Medicine Holdings Limited have?
Wai Yuen Tong Medicine Holdings Limited has 1,114,382,900 shares outstanding.
What happened to Wai Yuen Tong Medicine Holdings Limited’s price movement after its last earnings report?
Wai Yuen Tong Medicine Holdings Limited reported an EPS of HK$0.001 in its last earnings report. Following the earnings report the stock price went up 3.448%.
Which hedge fund is a major shareholder of Wai Yuen Tong Medicine Holdings Limited?
Currently, no hedge funds are holding shares in HK:0897
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology